In agreement with previous studies [45,46], our study also showed that VOdipic-Cl improves liver lipid metabolism disorders by down-regulating the expression of PPARγ, C/EBPa, SREBP-1c and FAS proteins related to lipid synthesis. The gene discussed is PPARG; the disease is Disorder of lipid metabolism.